January 25, 2013
Biotrial to Build
North American Headquarters in Newark
Biotrial S.A., a
clinical research organization based
in France that provides drug
discovery and developmental services
worldwide, recently purchased
approximately 1.2 acres in
University Heights Science Park
(UHSP) on which it plans to build
its North American headquarters.
UHSP recently
completed the sale of the land in an
area bounded by New, Norfolk and
Newark Streets.
Architecture firm
Francis Cauffman has completed the
master design plan for the facility
and expects to break ground in the
spring of 2013. Biotrial is
anticipating occupying the building
early in 2014.
Biotrial’s arrival
in Newark marks another significant
step in the continuing evolution of
a mixed use technology park in the
Science Park section of Newark’s
Central Ward, a strategy to drive
economic development for the
continued revitalization of the
area. UHSP is a collaborative
venture supported by the adjacent
education institutions – the
University of Medicine and Dentistry
of New Jersey (UMDNJ),
Rutgers-Newark, NJIT and Essex
County College – City, State and
Federal government, private industry
and community groups.
Thus far, a total of 351,000 square
feet of office, research and
technology space; a daycare center;
and 21 units of owner-occupied
housing have been developed within
Science Park, and more than 90
incubating companies are located
there. The UHSP initiative also
developed nearby Science Park High
School in partnership with the
Newark Public Schools district.
The Biotrial
initiative strongly supports a goal
of the 23-member UHSP Board of
Trustees to spur economic
development through the creation of
a range of jobs and the generation
of purchasing power.
The new facility
will become the North American
headquarters for Biotrial, which
manages more than 80 drug trials and
studies annually, many within its
own facilities in France and the
United Kingdom. It is
anticipated that the Biotrial
project will create 150-200
construction jobs initially and
eventually more than 100 permanent
healthcare jobs to support the
permanent Biotrial operation in
Newark.
The Science Park
leadership has enthusiastically
endorsed Biotrial’s establishing a
major research center here, citing
potential opportunities for new
significant scientific and economic
benefits for Newark and throughout
New Jersey. The leadership
also expressed its praise for
Lt. Governor Kim Guadagno for her
assistance in attracting Biotrial to
the Park.
Joel Bloom,
President of NJIT and Chairman of
the Science Park Board of Trustees,
said, “This is a significant
milestone for Science Park.
Achieving this commitment from
Biotrial continues the momentum for
developing a world-class science and
technology center in Newark.
It is especially exciting for the
Greater Newark community to have
this major commitment from Biotrial
to build its North American
headquarters here. Simply put, this
means hundreds of construction jobs
and permanent jobs to follow, and
greatly enhanced purchasing power
impacting the surrounding
communities, which address the
primary goals of the Science Park
leadership team.”
Jean-Marc Gandon,
President and Chief Executive
Officer of Biotrial, commented: “To
expand in North America, we needed
proximity to superior research and
medical facilities and to a major
transportation center. We
looked at many locations around the
world before deciding that Newark
and University Heights Science Park
best meet the many key requirements
and standards we have for conducting
our research.”
Worldwide,
Biotrial provides a wide range of
services, including Phase I studies,
clinical trial management of Phase
II, III and IV studies, data
management, biostatistics, ECG and
imaging core laboratory, medical
writing, non-clinical pharmacology,
regulatory affairs counseling, drug
evaluation and pharmacology research
services. Its primary areas of
drug therapy research include:
allergy, cardiovascular, CNS,
dermatology,
endocrinology/metabolism,
gastroenterology, hematology,
immunology, infectious diseases,
oncology, respiratory, rheumatology,
and women’s health.
|
